Jentadueto XR (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Jentadueto XR drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | linagliptin and metformin hydrochloride |
| SUBSTANCE NAME: | LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-05-27 |
| END MARKETING DATE: | 0000-00-00 |
Jentadueto XR HUMAN PRESCRIPTION DRUG Details:
| Item Description | Jentadueto XR from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 1000(mg/1; mg/1) |
| START MARKETING DATE: | 2016-05-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0270_7d0a946d-453b-82b9-3613-6b21ab5987fa |
| PRODUCT NDC: | 0597-0270 |
| APPLICATION NUMBER: | NDA208026 |
Other LINAGLIPTIN; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
